MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,314 | -78.5% | 149,066 | -44.2% | 0.00% | -50.0% |
| Q2 2023 | $879,318 | +4.6% | 267,270 | +30.6% | 0.00% | 0.0% |
| Q1 2023 | $840,840 | -76.8% | 204,584 | -66.9% | 0.00% | -81.8% |
| Q4 2022 | $3,620,478 | -21.5% | 617,829 | -9.4% | 0.01% | -31.2% |
| Q3 2022 | $4,611,000 | +121.3% | 682,082 | +51.2% | 0.02% | +128.6% |
| Q2 2022 | $2,084,000 | -59.1% | 451,174 | -64.6% | 0.01% | -53.3% |
| Q1 2022 | $5,090,000 | -6.8% | 1,275,634 | +45.3% | 0.02% | +25.0% |
| Q4 2021 | $5,460,000 | +66.3% | 877,752 | +152.1% | 0.01% | +71.4% |
| Q3 2021 | $3,284,000 | -57.1% | 348,245 | -38.3% | 0.01% | -58.8% |
| Q2 2021 | $7,660,000 | +22.8% | 564,030 | +46.3% | 0.02% | +6.2% |
| Q1 2021 | $6,239,000 | +18.2% | 385,570 | +94.4% | 0.02% | +6.7% |
| Q4 2020 | $5,278,000 | +69.0% | 198,333 | +18.2% | 0.02% | +36.4% |
| Q3 2020 | $3,124,000 | -39.2% | 167,767 | -23.5% | 0.01% | -56.0% |
| Q2 2020 | $5,134,000 | +1056.3% | 219,386 | +188.0% | 0.02% | +525.0% |
| Q1 2020 | $444,000 | +152.3% | 76,188 | +148.2% | 0.00% | +300.0% |
| Q4 2019 | $176,000 | -4.3% | 30,699 | -73.7% | 0.00% | 0.0% |
| Q3 2019 | $184,000 | +53.3% | 116,660 | +293.7% | 0.00% | – |
| Q2 2019 | $120,000 | -66.9% | 29,628 | -56.9% | 0.00% | -100.0% |
| Q1 2019 | $362,000 | +30.7% | 68,791 | +1.3% | 0.00% | 0.0% |
| Q4 2018 | $277,000 | – | 67,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |